DK361875A - Peptider med sterk lh-rh/fsh/rh-virkning og fremgangsmade til deres fremstilling - Google Patents

Peptider med sterk lh-rh/fsh/rh-virkning og fremgangsmade til deres fremstilling

Info

Publication number
DK361875A
DK361875A DK361875A DK361875A DK361875A DK 361875 A DK361875 A DK 361875A DK 361875 A DK361875 A DK 361875A DK 361875 A DK361875 A DK 361875A DK 361875 A DK361875 A DK 361875A
Authority
DK
Denmark
Prior art keywords
peptims
fsh
strong
procedure
preparation
Prior art date
Application number
DK361875A
Other languages
English (en)
Other versions
DK148905B (da
DK148905C (da
Inventor
W Konig
R Geiger
J K Sandow
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK361875A publication Critical patent/DK361875A/da
Priority to DK439683A priority Critical patent/DK148906C/da
Publication of DK148905B publication Critical patent/DK148905B/da
Application granted granted Critical
Publication of DK148905C publication Critical patent/DK148905C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK361875A 1974-08-09 1975-08-08 Analogifremgangsmaade til fremstilling af lh-rh-analoge nonapeptidderivater DK148905C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK439683A DK148906C (da) 1974-08-09 1983-09-26 Lh-rh-analoge nonapeptidderivater til diagnostisk anvendelse

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2438350A DE2438350C3 (de) 1974-08-09 1974-08-09 Peptide mit starker LH-RH/FSH-RH-Wirkung, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2438350 1974-08-09

Publications (3)

Publication Number Publication Date
DK361875A true DK361875A (da) 1976-02-10
DK148905B DK148905B (da) 1985-11-11
DK148905C DK148905C (da) 1986-04-07

Family

ID=5922833

Family Applications (1)

Application Number Title Priority Date Filing Date
DK361875A DK148905C (da) 1974-08-09 1975-08-08 Analogifremgangsmaade til fremstilling af lh-rh-analoge nonapeptidderivater

Country Status (15)

Country Link
US (1) US4024248A (da)
JP (1) JPS5761268B2 (da)
AT (1) AT364093B (da)
BE (1) BE832310A (da)
CA (1) CA1069888A (da)
CH (1) CH613186A5 (da)
DE (1) DE2438350C3 (da)
DK (1) DK148905C (da)
FR (1) FR2281132A1 (da)
GB (1) GB1523623A (da)
IE (1) IE41510B1 (da)
IL (1) IL47880A (da)
LU (1) LU73166A1 (da)
NL (1) NL182051C (da)
SE (2) SE424184B (da)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2617646C2 (de) * 1976-04-22 1986-07-31 Hoechst Ag, 6230 Frankfurt Nonapeptid-amide und Decapeptid-amide mit Gonadoliberin-Wirkung, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
GB1524747A (en) * 1976-05-11 1978-09-13 Ici Ltd Polypeptide
DE2735515A1 (de) * 1977-08-06 1979-02-22 Hoechst Ag Verwendung von lh-rh-peptiden als antikonzeptive
FR2450109B1 (fr) * 1977-11-08 1986-03-28 Roussel Uclaf Nouvelle methode de traitement utilisant la lh-rh, ou des agonistes
US4234571A (en) * 1979-06-11 1980-11-18 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone
IT1149971B (it) * 1979-06-11 1986-12-10 Syntex Inc Derivati nonapeptide e decapeptide dell'ormone che rilascia l'ormone luteinizzante
DE3020941A1 (de) * 1980-06-03 1981-12-17 Hoechst Ag, 6000 Frankfurt Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung
HU185535B (en) * 1982-05-25 1985-02-28 Mta Koezponti Hivatala Process for preparing new gonadoliberin derivatives
AT390066B (de) * 1983-03-29 1990-03-12 Richter Gedeon Vegyeszet Verfahren zur herstellung von neuen gonadoliberin-derivaten
HU187503B (en) * 1983-03-29 1986-01-28 Magyar Tudomanyos Akademia,Hu Process for preparing gonadoliberine derivatives containing beta-aspartyl group
DE3411224A1 (de) * 1984-03-27 1985-10-10 Hoechst Ag, 6230 Frankfurt Verfahren zur racematarmen herstellung von peptidzwischenprodukten der gonadorelin- und gonadorelinanaloga-synthese und neue zwischenprodukte bei diesem verfahren
US4775660A (en) * 1984-08-02 1988-10-04 Fernand Labrie Treatment of breast cancer by combination therapy
US4760053A (en) * 1984-08-02 1988-07-26 Fernand Labrie Combination therapy for selected sex steroid dependent cancers
US4666885A (en) * 1985-02-08 1987-05-19 Fernand Labrie Combination therapy for treatment of female breast cancer
HU193093B (en) * 1985-04-16 1987-08-28 Innofinance Process for stimulating sexual activity of birds and domestic mammalians and process for producing spermatocytes for their propagation
HU194280B (en) * 1985-10-22 1988-01-28 Richter Gedeon Vegyeszet Process for producing new gonadoliberin analogues of high effectivity and pharmaceutical compositions containing them
PH30747A (en) * 1989-03-10 1997-10-17 Endorech Inc Combination therapy for the treatment of estrogen sensitive disease.
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
JPH0235232A (ja) * 1989-06-29 1990-02-05 Nhk Spring Co Ltd 気室と液室を有する圧力容器
ES2121570T3 (es) * 1989-07-07 1998-12-01 Endorecherche Inc Derivados de androgenos para uso en la inhibicion de la actividad de los esteroides sexuales.
CA2062792C (en) * 1989-07-07 2006-03-21 Fernard Labrie Treatment of androgen-related diseases
CA2029018A1 (en) * 1989-11-01 1991-05-02 Robert P. Millar Analogues of gonadotropin releasing hormone
JPH0474770U (da) * 1990-10-31 1992-06-30
EP0641211A1 (en) * 1992-05-21 1995-03-08 Endorecherche Inc. INHIBITORS OF TESTOSTERONE 5$g(a)-REDUCTASE ACTIVITY
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
CA2192773C (en) 1995-12-15 2008-09-23 Hiroaki Okada Production of sustained-release preparation for injection
US6051558A (en) * 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
US20060025328A1 (en) * 1997-05-28 2006-02-02 Burns Patrick J Compositions suitable for controlled release of the hormone GnRH and its analogs
US6242421B1 (en) 1997-11-06 2001-06-05 Richard Lloyd Bowen Methods for preventing and treating Alzheimer's disease
ES2154590B1 (es) 1999-05-20 2001-11-01 Lipotec Sa Procedimiento de sintesis de peptidos en fase solida
AR023940A1 (es) 2000-05-03 2002-09-04 Eriochem Sa Procedimiento para la produccion de microcapsulas de liberacion prolongada de peptidos solubles en agua
EP1408876A4 (en) 2001-06-22 2004-09-22 Durect Corp ZERO ORDER COAXIAL IMPLANTS WITH EXTENDED RELEASE
US20060287282A1 (en) * 2001-06-25 2006-12-21 Steiner Mitchell S Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereof
DE60239207D1 (de) * 2001-08-10 2011-03-31 Takeda Pharmaceutical Gnrh-agonistische kombinationsmittel
WO2003041739A1 (en) 2001-11-13 2003-05-22 Takeda Chemical Industries, Ltd. Anticaner agents
US20030144203A1 (en) * 2001-12-19 2003-07-31 Voyager Pharmaceutical Corporation Methods for slowing senescence and treating and preventing diseases associated with senescence
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
CN101797221B (zh) 2002-12-13 2013-06-12 杜雷科特公司 包含高粘度液体载体材料的口服递药系统
GB0307777D0 (en) * 2003-04-04 2003-05-07 Medical Res Council Conjugate compounds
SI2767292T1 (sl) 2004-09-17 2017-01-31 Durect Corporation Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljšanim sproščanjem
US20090036435A1 (en) 2005-01-21 2009-02-05 Astex Therapeutics Limited Pharmaceutical Compounds
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US8882747B2 (en) * 2005-11-09 2014-11-11 The Invention Science Fund I, Llc Substance delivery system
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
ES2388355T3 (es) 2006-11-03 2012-10-11 Durect Corporation Sistemas de suministro transdémico que comprenden bupivacaína
AU2008347158B8 (en) 2007-12-06 2013-08-22 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
RU2444525C2 (ru) * 2010-06-09 2012-03-10 Закрытое Акционерное Общество "Фарм-Синтез" Способ получения нонапептидэтиламида и промежуточные соединения для его получения
MX2012014579A (es) 2010-06-16 2013-05-22 Endorech Inc Procedimientos de tratamiento o pevencion de enfermedades relacionadas con estrogenos.
WO2014144975A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
CN115666621A (zh) 2020-01-13 2023-01-31 度勒科特公司 具有减少的杂质的持续释放药物递送系统及相关方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5726506B2 (da) * 1974-03-08 1982-06-04
US3914412A (en) * 1973-10-11 1975-10-21 Abbott Lab {8 Des{13 Gly{9 {0 10 -Gn{13 RH nonapeptide amide analogs in position 6 having ovulation-inducing activity
US3901872A (en) * 1974-03-13 1975-08-26 American Home Prod P-glu-his-trp-ser-tyr-d-pgl-leu-arg-pro-gly-nh' 2 'and intermediates
US3896104A (en) * 1974-05-22 1975-07-22 American Home Prod P-glu-his-trp-ser-tyr-d-lys-leu-arg-pro-gly-nh' 2 'and intermediates

Also Published As

Publication number Publication date
IL47880A0 (en) 1975-11-25
JPS5761268B2 (da) 1982-12-23
LU73166A1 (da) 1977-04-13
US4024248A (en) 1977-05-17
DE2438350A1 (de) 1976-02-26
FR2281132A1 (fr) 1976-03-05
DK148905B (da) 1985-11-11
DK148905C (da) 1986-04-07
GB1523623A (en) 1978-09-06
IE41510L (en) 1976-02-09
NL182051C (nl) 1988-01-04
FR2281132B1 (da) 1979-09-14
IL47880A (en) 1978-10-31
NL182051B (nl) 1987-08-03
IE41510B1 (en) 1980-01-16
DE2438350C3 (de) 1979-06-13
SE7805545L (da) 1978-05-16
AT364093B (de) 1981-09-25
CA1069888A (en) 1980-01-15
ATA618975A (de) 1981-02-15
CH613186A5 (da) 1979-09-14
JPS5148659A (da) 1976-04-26
DE2438350B2 (de) 1978-10-26
SE424184B (sv) 1982-07-05
AU8374475A (en) 1977-02-10
SE7508926L (sv) 1976-02-10
NL7509260A (nl) 1976-02-11
BE832310A (fr) 1976-02-11

Similar Documents

Publication Publication Date Title
DK361875A (da) Peptider med sterk lh-rh/fsh/rh-virkning og fremgangsmade til deres fremstilling
DK495476A (da) Phenolethere og fremgangsmade til deres fremstilling
DK218175A (da) Peptider med lh-rh/fsh-rh-virkning og fremgangsmade til deres fremstilling
DK206975A (da) Svangerskabsforebyggende vaccine og fremgangsmade til fremstilling af samme
DK293575A (da) Triazolyl-alkanoner og -alkanoler samt fremgangsmade til deres fremstilling og deres anvendelse
DK240475A (da) Thiopolymere deres derivater og fremgangsmader til deres fremstilling og brug
DK299676A (da) Polyestere og fremgangsmader til deres fremstilling og anvendelse
DK588775A (da) D-homo-20-ketopregnaner og fremgangsmade til deres fremstilling
NO793035L (no) Nye jodbenzenderivater og fremgangsmaate for deres fremstilling
DK269175A (da) Fremgangsmade til fremstilling af d-phenylglycinamid og l-phenylglycin
DK398375A (da) N-acylamino-alfa-arylacetamidocephalosporiner og fremgangsmade til fremstilling heraf
DK401575A (da) Cis-decahydroisoquinolin-analgetika og fremgangsmade til deres fremstilling
DK367279A (da) 7-amino-3-cephem-4-carboxylsyrederivater og deres fremstilling
DK264475A (da) Makromolekylere adeninderivater og fremgangsmade til fremstilling heraf
DK412376A (da) Phenoxyalkylcarbonsyrer og fremgangsmade til deres fremstilling
DK411275A (da) Thiophensacchariner og fremgangsmade til fremstilling deraf
DK544075A (da) S-triazin-forpolymerisater og fremgangsmade til deres fremstilling
DK31576A (da) Acetylenderivater og fremgangsmade til deres fremstilling
DK247575A (da) Oxacyklohexanderivater og fremgangsmade til fremstilling deraf
DK269576A (da) Polyacetovinyldispersioner og fremgangsmade til fremstilling heraf
DK569275A (da) 1-alkyl-2-(phenoxymethyl)-5-nitro-imidazoler og fremgangsmade til deres fremstilling
DK270775A (da) Pesticide forbindelser og fremgangsmade til deres fremstilling og anvendelse
DK341576A (da) Homophthalimider og fremgangsmade til deres fremstilling
DK571775A (da) Tyrosinderivater og fremgangsmade til deres fremstilling
DK158175A (da) Tetracyclinderivater samt fremgangsmade til deres fremstilling og anvendelse

Legal Events

Date Code Title Description
PUP Patent expired